We are one of the largest medical centers in the country performing
transcatheter aortic valve replacement, or TAVR. This innovative
procedure is a treatment option for high-risk patients with severe aortic
stenosis who are not candidates for traditional heart valve surgeries.
Stanford heart surgeons are among the most experienced in the
country performing this revolutionary, new procedure.
When you come to Stanford Health Crae for transcatheter aortic valve
replacement, you benefit from:
Experience: We are a leader in the Bay Area for advanced
aortic stenosis treatment with the TAVR procedure. In fact, we are
one of only three hospitals in Northern California that performs
Our heart team has placed the new valve in over 400
patients since the clinical trial began in 2008.
Advanced options: Stanford Health Care was the first facility
in the Bay Area approved by the FDA to offer the Edwards SAPIEN
heart valve device outside of a clinical trial.
Leading research: Because Stanford Hospital was among select
hospitals nationwide to participate in the first TAVR clinical
trial, we have the advantage of years of research and experience
working with this device and contributing to its development as a
Collaborative care: Our experts work as a multidisciplinary
team to draw from a range of specialists. We provide comprehensive
assessment and treatments for patients with severe aortic stenosis,
with an emphasis on those considered high-risk for surgery. These
patients are good candidates for TAVR.
What is TAVR?
Transcatheter aortic valve replacement (TAVR) is an innovative and
FDA-approved, catheter-based therapy that provides a less invasive
approach to relieving aortic stenosis.
stenosis, a narrowing of the aortic valve opening, is one of the
most common and most serious valve disease problems.
The TAVR procedure involves implanting a prosthetic valve device
into your heart. At Stanford Health care, we use the Edwards SAPIEN
heart valve, a device made of bovine (cow) membrane attached to
a stainless steel mesh frame.
TAVR is a catheter-based procedure, which means it is minimally
invasive and utilizes a catheter, a long, thin flexible tube. During
the procedure, we will:
Make a tiny incision in the groin and thread the catheter –
carrying a balloon and the device – into the femoral artery in your
thigh and to your heart
Position the device in the aortic
Expand the balloon to open the valve and set it in
Once in place, the artificial valve takes over the function of the
aortic valve. There is no internal cutting and no heart-lung bypass needed.
Benefits of TAVR
TAVR is a lifesaving treatment option for patients with severe
aortic stenosis previously considered inoperable. With TAVR, there is
no need for open surgery or a heart-lung bypass – both of which carry
a higher risk of complications.
As a minimally invasive procedure, TAVR also leads to:
Faster, easier recovery than with open surgery
expectancy in very high-risk patients